Gravita India Fund Raise of ₹1,000 Cr

Gravita India Earnings Call Transcript: Key Takeaways

Gravita delivered resilient H1 growth despite geopolitical scrap sourcing headwinds. Management pivots to higher-margin copper recycling and US expansion to mitigate supply chain disruptions.

Call

Guides 25% growth

Gravita India Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs 1,427 Cr (+38% YoY), EBITDA Rs 143 Cr (+28%), PAT Rs 102 Cr (+6%); H1 revenue Rs 2,902 Cr. Copper entry via RMIL acquisition.

Gravita India Dividend

Gravita India fixes 3 November 2026 as the record date for determining members eligible for its FY2026-27 interim dividend. The letter gives no per-share amount.

Gravita India Q2 FY27 Results: Net Profit ₹102 Cr, Up 6.2% YoY

Gravita India Ltd reported revenue from operations of ₹1,427 Cr (+37.8% YoY) and net profit of ₹102 Cr (+6.2% YoY) for Q2 FY27.

Key figure

Net profit ₹102 Cr · +6.2% YoY

Gravita India Acquisition Worth ₹0.48 Cr

Gravita India acquires 100% of newly incorporated Gravita Recyclers USA Inc. for ₹0.48 Crore in cash. The target trades in scrap and scrap materials.

Value

₹0.48 Cr

Gravita India Merger & Restructuring Worth ₹0.48 Cr

Gravita India incorporated Gravita Recyclers USA Inc. as a wholly owned subsidiary for scrap trading. The US entity received an initial capital of ₹0.48 Crore.

Value

₹0.48 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.